Discontinuation report METOJECT
| Report ID | 164145 |
| Drug Identification Number | 02320029 |
| Brand name | METOJECT |
| Common or Proper name | Methotrexate sodium solution for injection |
| Company Name | MEDEXUS PHARMACEUTICALS INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METHOTREXATE |
| Strength(s) | 7.5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL |
| Packaging size | 1 PFS |
| ATC code | L01BA |
| ATC description | ANTIMETABOLITES |
| Reason for discontinuation | Other (Please describe in comments) |
| Anticipated discontinuation date | 2022-07-01 |
| Actual discontinuation date | 2022-06-29 |
| Remaining supply date | 2022-06-23 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Limited supply at wholesaler level |
| Company comments | Manufacturer is no longer producing the Metoject 7.5mg/0.75mL |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 35 NIXON ROAD, UNIT 10 BOLTON, ONTARIO CANADA L7E 1K1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2022-07-05 | French | Compare |
| v1 | 2022-07-05 | English | Compare |
Showing 1 to 2 of 2